

Biden's FTC took on big tech, big pharma and more. What antitrust legacy will Biden leave behind?
Oct 2, 2024
The podcast delves into the Biden administration's aggressive antitrust actions, including a record number of enforcement cases. It highlights the impact on consumers, particularly in the tech and pharmaceutical sectors, examining how companies manipulate patent laws. A heartfelt conversation also weaves in personal stories of loss and support, enhancing the narrative around mental health. The complexities of legal guidelines in antitrust regulation are discussed, along with the philosophical debates surrounding corporate growth and competition.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Intro
00:00 • 2min
A Heartfelt Conversation on Loss and Support
02:01 • 3min
Antitrust Revival: Biden's Competitive Agenda
04:33 • 12min
Exploring Antitrust Cases and Pharmaceutical Patent Manipulation
16:35 • 3min
FTC Battles Monopolies in Pharma
19:14 • 9min
Evaluating Antitrust Actions and Their Philosophical Roots
28:00 • 4min
Navigating Antitrust Complexities
32:03 • 20min